Status:
UNKNOWN
Autologous Micro-fragmented Adipose Tissue Injection for Knee Osteoarthritis
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Knee osteoarthritis (OA) is characterized by loss of cartilage leading to instability, reduced range of motion, and functional limitations. Current treatment has various limitations so that alternativ...
Eligibility Criteria
Inclusion
- Age of eighteen or older
- Diagnosis of symptomatic knee osteoarthritis
- Radiographic evidence of knee osteoarthritis
- Failure of conservative treatment
Exclusion
- Treatment with any intra-articular knee injection within 8 weeks before surgery
- Any disease or condition potential to interfere study outcome
- Under 18 years of age
Key Trial Info
Start Date :
January 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03788265
Start Date
January 1 2016
End Date
January 1 2021
Last Update
April 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Second affiliated hospital, school of medicine, Zhejiang Uni.
Hangzhou, Zhejiang, China, 310058